. . . . .-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018. . . http://lm360.us/Gezalyan-mother-of-Greeley-from-Pihlajamki?Sheehygra=106 . ., seventh-highest in the nation, and more than double the national average. .